CardiaMetrics is proud to be featured by Caen Normandie Développement, in an article looking at our journey and our mission to help clinicians anticipate cardiac decompensation before it puts patients in the hospital.

Read the full article (in French) on the Caen Normandie Développement website.

Rooted in the Normandy Ecosystem

Based at the Innova’Up incubator in Colombelles, CardiaMetrics has found in Normandy a supportive environment to grow, combining proximity to Caen University Hospital with a regional ecosystem committed to health innovation.

A Shared Mission: Anticipating Decompensation

The article highlights the challenge our team was founded to address: heart failure decompensation is too often caught only once a patient is already in crisis. Our subcutaneous sensor is designed to give clinicians earlier, continuous, and actionable insight into cardiac function, with early clinical work already underway in collaboration with Caen University Hospital.

Building Momentum

We’re grateful to Caen Normandie Développement and to the broader Normandy health-tech community for their continued support as CardiaMetrics keeps building toward its clinical and regulatory milestones. Stay tuned for more updates.

CardiaMetrics was pleased to take part in Heart Failure 2026, the annual congress of the Heart Failure Association of the European Society of Cardiology, held this year in Barcelona.

For the first time, CardiaMetrics had the opportunity to welcome visitors at its own booth, located in the Future Frontiers in Heart Failure Hub. This dedicated space provided an ideal setting to present our vision, share our latest progress, and engage directly with clinicians, researchers, and stakeholders from the international heart failure community.

Bringing Remote Monitoring Innovation Closer to Clinical Practice

Heart Failure 2026 was a valuable opportunity to discuss one of the central challenges in heart failure care: how to move from fragmented follow-up to continuous, clinically meaningful monitoring.

Today, many patients living with heart failure are still monitored through limited approaches, such as weight tracking, questionnaires, or hospital visits when symptoms worsen. While these methods remain useful, they often fail to capture early physiological changes that could support timely clinical intervention.

At our booth, we presented how CardiaMetrics is working to address this gap by developing a non-invasive monitoring solution designed to transform physiological signals into actionable insights for heart failure management.

Strong Scientific and Clinical Engagement

Throughout the congress, the CardiaMetrics team had the opportunity to exchange with leading experts in heart failure, as well as cardiologists interested in the future of remote monitoring and digital health.

These discussions were particularly valuable because they focused not only on the technology itself, but also on the clinical relevance of the results and their potential role in future care pathways.

The feedback we received was encouraging. Many visitors recognized the importance of developing scalable, patient-friendly solutions capable of supporting earlier detection of clinical deterioration and helping clinicians make more informed decisions.

A Shared Need for Better Monitoring Solutions

One of the key insights from the congress was clear: the need for better heart failure monitoring is widely acknowledged.

As therapies continue to evolve and care pathways become more personalized, clinicians need reliable tools to better understand patient status over time. Remote monitoring should not simply generate more data; it must help transform data into meaningful information that can support clinical decisions.

This perspective is strongly aligned with CardiaMetrics’ mission: to provide clinically relevant insights that help bridge the gap between patient monitoring, therapeutic adjustment, and improved outcomes.

A Meaningful Step Forward for CardiaMetrics

Heart Failure 2026 marked an important moment for CardiaMetrics. Having a dedicated booth allowed us to present our work in a more structured and engaging way, demonstrate our progress, and strengthen our dialogue with the heart failure community.

The congress confirmed the growing interest in innovative monitoring approaches and reinforced the relevance of our work at the intersection of cardiovascular care, physiological signal analysis, and digital health.

Looking Ahead

We would like to thank everyone who visited our booth, shared their questions, and contributed to meaningful discussions throughout the congress.

As CardiaMetrics continues to advance, we remain committed to developing scalable, clinically relevant monitoring solutions that support earlier intervention and bring heart failure care closer to the needs of patients and care teams.

We look forward to continuing these conversations and to sharing our next steps with the heart failure community.

CardiaMetrics is pleased to announce its participation in Heart Failure 2026, the annual congress of the Heart Failure Association of the European Society of Cardiology, taking place from 9 to 12 May 2026 in Barcelona, Spain. The congress will bring together the international heart failure community to explore the latest advances in science, clinical practice, digital health, and patient care.

Sharing Our Latest Progress in Heart Failure Monitoring

This year’s congress theme, “Evolution in Heart Failure,” strongly resonates with CardiaMetrics’ mission: transforming remote monitoring data into clinically actionable insights for patients living with heart failure.

At our booth, we will be pleased to share our latest company updates, including recent progress in clinical development, scientific validation, and the continued advancement of our remote monitoring solution. Our team looks forward to presenting how CardiaMetrics is working to support earlier detection of clinical deterioration and strengthen decision-making in heart failure care.

Connecting With the Heart Failure Community

Heart Failure 2026 will place a strong focus on breakthrough therapies, novel devices, AI-powered tools, remote monitoring, and digital health solutions that are shaping the future of cardiovascular care.

For CardiaMetrics, this congress represents an important opportunity to exchange with clinicians, researchers, healthcare institutions, industry partners, and innovation leaders. These conversations are essential to ensure that new technologies remain grounded in real clinical needs and can contribute meaningfully to improved patient outcomes.

Meet Us in Barcelona

We are excited to welcome visitors to our booth in the Future Frontiers in Heart Failure Hub — E300 throughout the congress. Whether you are a clinician, researcher, partner, investor, or healthcare stakeholder, we would be pleased to meet you, introduce our latest developments, and discuss how remote monitoring can help support the evolution of heart failure care.

As CardiaMetrics continues to grow, Heart Failure 2026 marks another important step in our journey to bring scalable, clinically relevant monitoring solutions closer to patients and care teams.

We look forward to seeing you in Barcelona. #HeartFailure26

CardiaMetrics is proud to be featured on the Grenoble INP – UGA website, in a piece dedicated to research valorization that retraces our journey from an academic research project at the TIMC laboratory to a growing medtech start-up.

Read the full article (in French) on the Grenoble INP – UGA website.

From the Lab to the Clinic

The feature highlights how years of research within the Grenoble academic ecosystem laid the scientific groundwork for CardiaMetrics’ subcutaneous sensor, designed to give clinicians continuous, actionable insight into cardiac function without requiring any action from the patient.

A Recognition of Grenoble’s Research-to-Industry Pipeline

Being featured by Grenoble INP – UGA is a meaningful nod to the strength of the research-to-industry pipeline that made CardiaMetrics possible. It reflects the value of long-term academic research when it is paired with the ambition to bring a solution to patients at scale, bridging the gap between deep science and clinically relevant, scalable remote monitoring.

Building Momentum

This recognition adds to a period of steady progress for CardiaMetrics, and we’re grateful to Grenoble INP – UGA and the broader research community for the foundation their work has given us. Stay tuned for more updates as we continue building toward our clinical and regulatory milestones.

Credits : Adobe Stock

CardiaMetrics is proud to be featured in Présences Grenoble, highlighting our journey and our ambition to transform heart failure care through innovative monitoring technologies.

Read the full article on Présences Grenoble.

A Growing Medtech Presence in Grenoble

The article highlights CardiaMetrics’ presence in the Grenoble ecosystem, a region recognized for its strong deeptech and healthcare innovation environment. Alongside our roots in Normandy, our footprint in Grenoble reinforces our ability to combine scientific excellence, engineering, and clinical partnerships.

This dual anchoring reflects our ambition to build a high-impact medtech company at the intersection of research, technology, and patient care.

Addressing a Major Unmet Medical Need

CardiaMetrics is developing a home-based remote monitoring solution for patients with heart failure, a chronic disease affecting millions worldwide.

As emphasized in the article, heart failure management remains a major challenge due to the difficulty of detecting early signs of decompensation. Our approach aims to provide continuous, reliable, and actionable physiological insights, enabling clinicians to intervene earlier and improve patient outcomes.

Innovation at the Core: Data, Sensors, and AI

The Présences Grenoble feature underlines the technological foundations of our solution, combining:

• Advanced physiological sensing
• Data science and machine learning
• A strong clinical validation strategy

By leveraging these pillars, CardiaMetrics is working to deliver scalable and clinically relevant monitoring, bridging the gap between traditional telemonitoring and more invasive solutions.

Building Momentum

This media recognition reflects the progress CardiaMetrics has made over the past months — from team growth and clinical development to increased visibility within the innovation ecosystem.

We are grateful for the continued support of our partners, investors, and the broader medtech community as we move forward.

CardiaMetrics is proud to announce that we have been selected to join the Deeptech Accelerator program led by Bpifrance, becoming the only startup from Normandy to be part of this prestigious cohort.

This recognition marks an important milestone in our journey to transform heart failure care through innovative remote monitoring technologies.

Read the full media coverage by Ouest-France

Recognition of Our Deeptech Vision

The Deeptech Accelerator supports high-impact startups developing breakthrough technologies grounded in strong scientific foundations. CardiaMetrics’ selection reflects the relevance of our approach combining advanced sensing technologies, machine learning, and clinical research to improve the management of heart failure patients.

Being part of this program will help us structure our growth, strengthen our industrial strategy, and accelerate clinical development, while benefiting from mentorship, funding support, and access to a powerful innovation ecosystem.

Strengthening Our Development Roadmap

Since our creation, CardiaMetrics has focused on building a clinically driven innovation, working closely with healthcare professionals and research partners to validate the safety and performance of our technology.

Participation in the Deeptech Accelerator will enable us to:

• Accelerate product development and regulatory readiness
• Expand clinical evidence generation
• Reinforce our strategic positioning in the heart failure monitoring market
• Scale our impact across France and internationally

A Collective Achievement

This milestone reflects the dedication of our growing team, the trust of our investors, and the support of our clinical partners.

We are honored to contribute to the dynamism of the Normandy deeptech ecosystem and to help position French innovation at the forefront of cardiovascular care.

Stay tuned for more updates as we continue to advance toward the next stages of clinical validation and market access.

We’re excited to share that CardiaMetrics was recently featured on RCF-Isère Radio’s Parole de leader programme, a series dedicated to showcasing leaders, entrepreneurs, and innovators shaping the economic and social landscape.

In this interview, Thibault Parmentier, CEO and co-founder of CardiaMetrics, spoke about our journey, our mission to improve the lives of patients living with chronic heart failure, and how our unique approach to telemonitoring can help clinicians anticipate cardiac decompensations before they become critical.

What We Discussed

• The inspiration behind CardiaMetrics and how we are building on years of research to develop an implantable telemonitoring solution.

• The clinical challenges of heart failure, and why early detection and continuous monitoring are essential for improving patient outcomes.

• How our technology works, with automated physiological data collection and predictive insights that empower clinicians to act proactively.

• The importance of collaboration with clinical partners and how evidence-based innovation is at the core of our strategy.

This radio feature is a meaningful opportunity to share our vision with a wider audience and highlight the real-world impact of innovation in cardiac care. We encourage all our community — patients, clinicians, partners, and supporters — to listen to the interview and gain insight into our mission.

Listen to the Parole de leader episode on RCF Radio (Economy & Society segment) to hear the full conversation with Thibault Parmentier.

Stay tuned to our blog for more media highlights and updates from the CardiaMetrics team!